Hull Prospective Analysis of OnabotulinumtoxinA (Botox) in the treatment of Chronic Migraine; a real-life data in 972 patients; updated results on over 8 years of experience

被引：0
|
作者：
Ahmed, Fayyaz [1 ]
Buture, Alina [1 ]
Tanvir, Taukir [1 ]
Khalil, Modar [1 ]
机构：
[1] Hull York Med Sch, Neurosci, Kingston Upon Hull, N Humberside, England
来源：
CEPHALALGIA | 2019年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
IHC-PO-423
引用
收藏
页码：276 / 277
页数：2
相关论文
共 50 条
  • [31] Two Year Real World Prospective Quality of Life Data in Treatment Refractory Chronic Migraine Patients Treated with Erenumab in Ireland
    Troy, E.
    Shrukalla, A. A.
    Buture, A.
    Conaty, K.
    Macken, E.
    Lonergan, R.
    Melling, J.
    Long, N.
    Shaikh, E.
    Tomkins, E.
    Ruttledge, M.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 121 - 122
  • [32] Two Year Real World Prospective Quality of Life Data in Treatment Refractory Chronic Migraine Patients Treated with Erenumab in Ireland
    Troy, E.
    Shrukalla, A. A.
    Buture, A.
    Conaty, K.
    Macken, E.
    Lonergan, R.
    Melling, J.
    Long, N.
    Shaikh, E.
    Tomkins, E.
    Ruttledge, M.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 181 - 181
  • [33] Real-Life Data and a Single Center Experience on the Efficacy and Toxicity Profile of Imatinib in the Treatment of Elderly Patients with Chronic Myeloid Leukemia
    Eskazan, Ahmet Emre
    Oztas, Mert
    Bektas, Fatih
    Sadri, Sevil
    Keskin, Dilek
    Yurttas, Nurgul Ozgur
    Berk, Selin
    Ozunal, Isil Erdogan
    Salihoglu, Ayse
    Ar, M. Cem
    Ongoren, Seniz
    Baslar, Zafer
    Ozbek, Ugur
    Aydin, Yildiz
    Soysal, Teoman
    BLOOD, 2016, 128 (22)
  • [34] Efficacy and Safety of Imatinib Treatment in Elderly Patients With Chronic Myeloid Leukemia: Real-Life Data and a Single-Center Experience
    Eskazan, Ahmet Emre
    Ozmen, Deniz
    Oztas, Mert
    Bektas, Fatih
    Bayraktar, Esref Alperen
    Sadri, Sevil
    Keskin, Dilek
    Yurttas, Nurgul Ozgur
    Elverdi, Tugrul
    Salihoglu, Ayse
    Ar, Muhlis Cem
    Ongoren, Seniz
    Baslar, Zafer
    Aydin, Yildiz
    Soysal, Teoman
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (08): : 549 - 557
  • [35] Retrospective Analysis of Hairy Cell Leukemia Patients Treated with Different Modalities as First Line: Real-Life Experience Over 20 years
    Fergün Yılmaz
    Dilan Atilla
    Nagihan Akkaş
    Hale Bülbül
    Nur Soyer
    Derya Demir
    Demet Kiper
    Aylin Avcı
    Filiz Vural
    Güray Saydam
    Fahri Şahin
    Mine Hekimgil
    Nazan Özsan
    Raika Durusoy
    Bahriye Payzın
    Indian Journal of Hematology and Blood Transfusion, 2019, 35 : 692 - 698
  • [36] Retrospective Analysis of Hairy Cell Leukemia Patients Treated with Different Modalities as First Line: Real-Life Experience Over 20 years
    Yilmaz, Fergun
    Atilla, Dilan
    Akkas, Nagihan
    Bulbul, Hale
    Soyer, Nur
    Demir, Derya
    Kiper, Demet
    Avci, Aylin
    Vural, Filiz
    Saydam, Gueray
    Sahin, Fahri
    Hekimgil, Mine
    Ozsan, Nazan
    Durusoy, Raika
    Payzin, Bahriye
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2019, 35 (04) : 692 - 698
  • [37] A 24-month, Prospective, Non-interventional Study to Describe the Long Term, Real-life Use of BOTOX® for the Symptomatic Treatment of Adults with Chronic Migraine Observed in Practice (REPOSE study): 6 months Interim Analysis
    Ahmed, Fayyaz
    Pascual, Julio
    Geevarghese, Hanson
    Brown, Stephanie
    HEADACHE, 2015, 55 : 264 - 264
  • [38] Treatment discontinuation following low-dose TKIs in 248 chronic myeloid leukemia patients: Updated results from a campus CML real-life study
    Iurlo, A.
    Cattaneo, D.
    Consonni, D.
    Castagnetti, F.
    Miggiano, M. C.
    Binotto, G.
    Bonifacio, M.
    Rege-Cambrin, G.
    Tiribelli, M.
    Lunghi, F.
    Gozzini, A.
    Pregno, P.
    Abruzzese, E.
    Capodanno, I.
    Bucelli, C.
    Pizzuti, M.
    Artuso, S.
    Iezza, M.
    Scalzulli, E.
    La Barba, G.
    Maggi, A.
    Russo, S.
    Elena, C.
    Scortechini, A. R.
    Tafuri, A.
    Latagliata, R.
    Caocci, G.
    Bocchia, M.
    Galimberti, S.
    Luciano, L.
    Fava, C.
    Foa, R.
    Saglio, G.
    Rosti, G.
    Breccia, M.
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [39] Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy (vol 8, 586, 2017)
    Guerzoni, Simona
    Pellesi, Lanfranco
    Baraldi, Carlo
    Cainazzo, Michela Maria
    Negro, Andrea
    Martelletti, Paolo
    Pini, Luigi Alberto
    FRONTIERS IN NEUROLOGY, 2018, 9
  • [40] Favorable safety profile of moderate hypofractionated over normofractionated radiotherapy in breast cancer patients: a multicentric prospective real-life data farming analysis
    Issoufaly, Irfane
    Petit, Claire
    Guihard, Sebastien
    Eugene, Remi
    Jung, Loic
    Clavier, Jean Baptiste
    Servagi Vernat, Stephanie
    Bellefqih, Sara
    Verret, Benjamin
    Bonnet, Naima
    Deutsch, Eric
    Rivera, Sofia
    RADIATION ONCOLOGY, 2022, 17 (01)
12345